Christopher L. Amling
Papers
5
Total Citations
176
H-Index
4
About
Christopher L. Amling is a leading urologic oncologist whose research has profoundly shaped the surgical management of prostate and bladder cancers. His work centers on comparing the effectiveness and outcomes of open versus robotic-assisted surgical techniques, with a particular focus on radical cystectomy and radical prostatectomy. Dr. Amling’s major contributions include landmark multi-institutional analyses, such as his 2011 study on robotic radical cystectomy, which provided critical perioperative outcomes and complication data for 227 patients, earning 116 citations. He has also investigated predictors of operative time and cost-to-patient factors, helping to optimize surgical scheduling and reduce healthcare expenses. His research on obese men undergoing radical prostatectomy offers vital insights into minimizing positive surgical margins, while his work on pelvic lymph node dissection has clarified surgical technique utilization across risk groups. With studies published in high-impact journals and supported by large databases like the Shared Equal Access Regional Cancer Hospital (SEARCH), Dr. Amling’s evidence-based findings continue to guide clinical decision-making and improve patient outcomes in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5